albendazole has been researched along with Communicable Diseases in 2 studies
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costantini, S | 1 |
| Walensky, RP | 1 |
| Webb, EL | 1 |
| Mawa, PA | 1 |
| Ndibazza, J | 1 |
| Kizito, D | 1 |
| Namatovu, A | 1 |
| Kyosiimire-Lugemwa, J | 1 |
| Nanteza, B | 1 |
| Nampijja, M | 1 |
| Muhangi, L | 1 |
| Woodburn, PW | 1 |
| Akurut, H | 1 |
| Mpairwe, H | 1 |
| Akello, M | 1 |
| Lyadda, N | 1 |
| Bukusuba, J | 1 |
| Kihembo, M | 1 |
| Kizza, M | 1 |
| Kizindo, R | 1 |
| Nabulime, J | 1 |
| Ameke, C | 1 |
| Namujju, PB | 1 |
| Tweyongyere, R | 1 |
| Muwanga, M | 1 |
| Whitworth, JA | 1 |
| Elliott, AM | 1 |
1 trial available for albendazole and Communicable Diseases
| Article | Year |
|---|---|
Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Albendazole; Anthelmintics; Communicable Diseases; Dose-Response Relationship, Drug; Double-B | 2011 |
1 other study available for albendazole and Communicable Diseases
| Article | Year |
|---|---|
The Costs of Drugs in Infectious Diseases: Branded, Generics, and Why We Should Care.
Topics: Albendazole; Communicable Diseases; Costs and Cost Analysis; Drug Costs; Drug Industry; Drugs, Gener | 2020 |